Persistence of airway inflammation in smokers who switch to electronic cigarettes

Michael D Kim; Nathalie Baumlin; Andrea Guerrero-Cignarella; Andreas Schmid; Carolina Aguiar; Mohiuddin Mohiuddin; John S Dennis; Jasjit S Ahluwalia; Eleanor L Leavens; Nikki Nollen; Michael Campos; Matthias Salathe

doi:10.1183/23120541.00117-2022

Persistence of airway inflammation in smokers who switch to electronic cigarettes

ERJ Open Res. 2022 Jun 20;8(2):00117-2022. doi: 10.1183/23120541.00117-2022. eCollection 2022 Apr.

Authors

Affiliations

¹ Dept of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
² Division of Pulmonary, Critical Care and Sleep Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
³ Dept of Behavioral and Social Science, Brown University School of Public Health, Providence, RI, USA.
⁴ Dept of Medicine, Alpert Medical School, Providence, RI, USA.
⁵ Dept of Population Health, University of Kansas Medical Center, Kansas City, KS, USA.

Abstract

As opposed to smoking cessation with nicotine-replacement therapy and/or varenicline, nicotine-containing e-cigarette use does not improve some airway inflammatory markers. https://bit.ly/3FyqIt9.

Abstract

Grants and funding